Cargando…

Towards reproducible computational drug discovery

The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaduangrat, Nalini, Lampa, Samuel, Simeon, Saw, Gleeson, Matthew Paul, Spjuth, Ola, Nantasenamat, Chanin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988305/
https://www.ncbi.nlm.nih.gov/pubmed/33430992
http://dx.doi.org/10.1186/s13321-020-0408-x
_version_ 1783492241236426752
author Schaduangrat, Nalini
Lampa, Samuel
Simeon, Saw
Gleeson, Matthew Paul
Spjuth, Ola
Nantasenamat, Chanin
author_facet Schaduangrat, Nalini
Lampa, Samuel
Simeon, Saw
Gleeson, Matthew Paul
Spjuth, Ola
Nantasenamat, Chanin
author_sort Schaduangrat, Nalini
collection PubMed
description The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code.
format Online
Article
Text
id pubmed-6988305
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-69883052020-02-03 Towards reproducible computational drug discovery Schaduangrat, Nalini Lampa, Samuel Simeon, Saw Gleeson, Matthew Paul Spjuth, Ola Nantasenamat, Chanin J Cheminform Review The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code. Springer International Publishing 2020-01-28 /pmc/articles/PMC6988305/ /pubmed/33430992 http://dx.doi.org/10.1186/s13321-020-0408-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Schaduangrat, Nalini
Lampa, Samuel
Simeon, Saw
Gleeson, Matthew Paul
Spjuth, Ola
Nantasenamat, Chanin
Towards reproducible computational drug discovery
title Towards reproducible computational drug discovery
title_full Towards reproducible computational drug discovery
title_fullStr Towards reproducible computational drug discovery
title_full_unstemmed Towards reproducible computational drug discovery
title_short Towards reproducible computational drug discovery
title_sort towards reproducible computational drug discovery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988305/
https://www.ncbi.nlm.nih.gov/pubmed/33430992
http://dx.doi.org/10.1186/s13321-020-0408-x
work_keys_str_mv AT schaduangratnalini towardsreproduciblecomputationaldrugdiscovery
AT lampasamuel towardsreproduciblecomputationaldrugdiscovery
AT simeonsaw towardsreproduciblecomputationaldrugdiscovery
AT gleesonmatthewpaul towardsreproduciblecomputationaldrugdiscovery
AT spjuthola towardsreproduciblecomputationaldrugdiscovery
AT nantasenamatchanin towardsreproduciblecomputationaldrugdiscovery